GDRX - GoodRx Holdings, Inc. -  [ ]

Ticker Details
GoodRx Holdings, Inc.
IPO Date: September 23, 2020
Sector: Healthcare
Industry: Health Information Services
Market Cap: $781.07M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.42 | 2.74%
Avg Daily Range (30 D): $0.10 | 4.48%
Avg Daily Range (90 D): $0.07 | 2.77%
Institutional Daily Volume
Avg Daily Volume: 1.96M
Avg Daily Volume (30 D): 3.89M
Avg Daily Volume (90 D): 2.74M
Trade Size
Avg Trade Size (Sh.): 125
Avg Trade Size (Sh.) (30 D): 224
Avg Trade Size (Sh.) (90 D): 204
Institutional Trades
Total Institutional Trades: 2,655
Avg Institutional Trade: $1.83M
Avg Institutional Trade (30 D): $.98M
Avg Institutional Trade (90 D): $.99M
Avg Institutional Trade Volume: .09M
Avg Institutional Trades (Per Day): 3
Market Closing Trades
Avg Closing Trade: $2.24M
Avg Closing Trade (30 D): $.59M
Avg Closing Trade (90 D): $.9M
Avg Closing Volume: 124.02K
 
News
Feb 6, 2026 @ 1:15 AM
Amazon Is Now Offering Novo Nordisk's Wegovy Pill ...
Source: Reuben Gregg Brewer
Jan 5, 2026 @ 5:23 PM
Novo Nordisk's Wegovy Weight Loss Pill Hits US Pha...
Source: Vandana Singh
Nov 17, 2025 @ 6:01 PM
Novo Nordisk Leans Into Affordability Amid Rising ...
Source: Vandana Singh
Sep 18, 2025 @ 2:00 PM
Telepharmacy Market Size to Reach US$ 21.89 Billio...
Source: S&S Insider Research
Aug 18, 2025 @ 3:36 PM
Ozempic And Wegovy Now Available Through GoodRx At...
Source: Vandana Singh
Financials
  TTM Q4 2025 FY 2025
Basic EPS $.09 $.02 $.09
Diluted EPS $.09 $.02 $.09
Revenue $796.85M $194.79M $796.85M
Gross Profit
Net Income / Loss $30.44M $5.43M $30.44M
Operating Income / Loss $87.49M $22.68M $87.49M
Cost of Revenue
Net Cash Flow $-186.53M $-11.71M $-186.53M
PE Ratio 0.00